Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bill Takes Small Step Toward More Nanotech Research, Commercialization

This article was originally published in The Tan Sheet

Executive Summary

Nanotechnology researchers and consumer safety advocates say Congress should expedite legislation to direct and fund research necessary to spur further nanotech commercialization and adequately protect the public from possible dangers

You may also be interested in...



Nano strategy flawed

The National Nanotechnology Initiative lacks "an overarching research strategy" and overlooks the "lack of studies on how to manage consumer and environmental risks" caused by nanomaterial exposure through consumer products, the nonprofit National Research Council says Dec. 10. A report by NRC's Committee on Review of the Federal Strategy to Address Environmental, Health and Safety Research Needs for Engineered Nanoscale Materials recommends a "robust national strategic plan" with a broad spectrum of research from academia, industry and consumer and environmental advocates. In a same-day release, Rep. Bart Gordon, D-Tenn., chairman of the Committee on Science and Technology, says his committee plans to reintroduce the National Nanotechnology Initiative Amendments Act in the new Congress. The bill, which passed the House in June but faltered in the Senate, is "aimed at correcting weaknesses in the federal research program" by setting research goals and multi-year funding requirements, Gordon says (1"The Tan Sheet" June 23, 2008, p. 11)

Nano strategy flawed

The National Nanotechnology Initiative lacks "an overarching research strategy" and overlooks the "lack of studies on how to manage consumer and environmental risks" caused by nanomaterial exposure through consumer products, the nonprofit National Research Council says Dec. 10. A report by NRC's Committee on Review of the Federal Strategy to Address Environmental, Health and Safety Research Needs for Engineered Nanoscale Materials recommends a "robust national strategic plan" with a broad spectrum of research from academia, industry and consumer and environmental advocates. In a same-day release, Rep. Bart Gordon, D-Tenn., chairman of the Committee on Science and Technology, says his committee plans to reintroduce the National Nanotechnology Initiative Amendments Act in the new Congress. The bill, which passed the House in June but faltered in the Senate, is "aimed at correcting weaknesses in the federal research program" by setting research goals and multi-year funding requirements, Gordon says (1"The Tan Sheet" June 23, 2008, p. 11)

Nano strategy flawed

The National Nanotechnology Initiative lacks "an overarching research strategy" and overlooks the "lack of studies on how to manage consumer and environmental risks" caused by nanomaterial exposure through consumer products, the nonprofit National Research Council says Dec. 10. A report by NRC's Committee on Review of the Federal Strategy to Address Environmental, Health and Safety Research Needs for Engineered Nanoscale Materials recommends a "robust national strategic plan" with a broad spectrum of research from academia, industry and consumer and environmental advocates. In a same-day release, Rep. Bart Gordon, D-Tenn., chairman of the Committee on Science and Technology, says his committee plans to reintroduce the National Nanotechnology Initiative Amendments Act in the new Congress. The bill, which passed the House in June but faltered in the Senate, is "aimed at correcting weaknesses in the federal research program" by setting research goals and multi-year funding requirements, Gordon says (1"The Tan Sheet" June 23, 2008, p. 11)

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101786

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel